Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

The Differences of Acute Myocardial Infarction in Women in Clinical Characteristics and Treatment

Pyun WB

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Trimetazidine on the Enhancement Patterns of Multi-Detector Computed Tomography in a Porcine Myocardial Infarction Model: What is the Meaning of the MDCT Enhancement Pattern in this Myocardial Infarction Model?

Jung JI

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cases of Right Ventricular Myocardial Infarction in Patients with an Absent or Hypoplastic Right Coronary Artery

Kim MS, Han JK, Lee SE, Kim SY, Park KW, Koo BK, Lee HY

Two cases of myocardial infarction in the right ventricular (RV) wall, as well as the inferior wall, due to occlusion of the left circumflex coronary artery, with an absent or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sex Differences of the Clinical Characteristics and Early Management in the Korea Acute Myocardial Infarction Registry

Lee KH, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, Cho JG, Park SJ

BACKGROUND AND OBJECTIVES: The first on-line registration of Korea Acute Myocardial Infarction patients (KAMIRs) has been carried out throughout the 41 primary percutaneous coronary intervention (PCI) centers that are supported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is Stent Underexpansion the Main Cause of In-Stent Restenosis after Sirolimus-Eluting Stent Implantation?: An Intravascular Ultrasound Study

Kim BK, Oh SJ, Jeon DW, Kim KH, Yang JY

BACKGROUND AND OBJECTIVES: Intravascular ultrasound (IVUS) can be useful for assessing the causes of in-stent restenosis (ISR) after sirolimus-eluting stent (SES) implantation. We used IVUS to evaluate the causes of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intracoronary Stent Deployment without Antiplatelet Agents in a Patient with Idiopathic Thrombocytopenic Purpura

Park HJ, Seung KB, Kim PJ, Kang HH, Park CS, Kil UH, Choi MS, Baek SH, Kim JH, Choi KB

Deciding on the appropriate antiplatelet therapy is a challenge when treating patients with idiopathic thrombocytopenic purpura (ITP) and who are undergoing percutaneous coronary intervention (PCI). We describe here a case...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Slight Variation in the Age of Rats Commonly used as a Carotid Artery Injury Model Results in a Large Difference in Neointima Formation

Kwon JS, Park NK, Jeong IH, Kim YK, Bae JH, Hwang KK, Kim DW, Cho MC

BACKGROUND AND OBJECTIVES: The degree of neointima formation after infliction of a carotid artery balloon injury in rats varies greatly depending on the sex, age, species and operational method. Strong...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Feasibility of Transradial Primary Percutaneous Coronary Intervention with an ST Elevation Acute Myocardial Infarction

Park SJ, Park JH, Lee JH, No SP, Park HS, Park YK, Lee MS, Choi SW, Jeong JO, Seong IW

BACKGROUND AND OBJECTIVES: With the lower incidence of bleeding complications and earlier ambulation, transradial coronary intervention (TRI) is related with improved patient satisfaction compared with that of conventional transfemoral intervention...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Trimetazidine on the Enhancement Pattern of Multi-detector Computed Tomography in a Porcine Myocardial Infarction Model

Lee SR, Jeong MH, Yim NY, Yoon NS, Kim KH, Hong YJ, Park HW, Kim JH, Moon JY, Ahn YK, Kim YH, Cho JG, Park JC, Kang JC

BACKGROUND AND OBJECTIVES: There is increasing evidence to suggest that trimetazidine (TMZ) has the ability to improve ischemic heart failure by way of optimizing the heart's energy metabolism. The aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr